Upper Respiratory InfectionsNCT01971112
Nutritional Intervention and Respiratory Infections in Older Subjects
A study testing Multivitamins and minerals in people with Upper Respiratory Infections and Lower Respiratory Tract Infections, run by Corporacion Ecuatoriana de Biotecnologia at 1 site in Ecuador.
Trial summary
Poor Ecuadorian older people suffer from chronic dietary deficiencies of zinc, iron, copper, vitamins C, B6, B12, D, and folic acid. The investigators have previously shown that these deficiencies are associated with impaired immune function and increased incidence of respiratory infections (RI). Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Upper Respiratory Infections, Lower Respiratory Tract Infections
- What is being tested?
- Multivitamins and minerals
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 320 participants
- Where
- 1 siteEcuador
- Study dates
- Oct 2013to Dec 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Age ≥65 years
- Mental competence
- Written informed consent
Who cannot join
- Cancer
- Tuberculosis
- Immunosuppressive therapeutics.
Trial locations and contacts
1 site in 1 country.
Ecuador1 site, 1 recruiting
- Recruiting
Atucucho neighborhood
Quito, Pichincha
Fernando E Sempertegui, MD, 593 2 2557673, fersempert@biociencias-ceb.org
Fernando E Sempertegui, MD
About this study
Official title: Effect of Supplementation With Multivitamins and Minerals on the Incidence of Respiratory Infections in Older People in Ecuador: a Randomised Controlled Trial.
Poor Ecuadorian older people suffer from chronic dietary deficiencies of zinc, iron, copper, vitamins C, B6, B12, D, and folic acid. The investigators have previously shown that these deficiencies are associated with impaired immune function and increased incidence of respiratory infections (RI). The hypothesis is that correction of these specific nutrient deficiencies will improve immune response and thereby enhance resistance to respiratory infections. To test this hypothesis this study will evaluate the effect of supplementation with specific vitamins and minerals found to be deficient in poor elderly Ecuadorians on markers of immune function and the incidence of RI. A randomized, double-blind, placebo-controlled trial in 320 older people (≥65 y)will be carried out in Quito, Ecuador. Participants will receive multivitamin and mineral supplements or placebo tablets daily for 12 months. Nutrients will be provided at US Recommended Daily Allowance (RDA) levels, except for vitamin C and zinc doses, which will be 5 times and 1.25 times higher than the RDA, respectively. Incidence of respiratory infections (the primary outcome) will be assessed weekly by field nurses and physicians from the study team. Secondary outcomes include delayed-type hypersensitivity (DTH) skin test, cathelicidin production by mucosa respiratory cells, and serum C-reactive protein (CRP) as measures of immune function. Blood micronutrient levels and haemoglobin status will be collected as measures of adherence to the trial regimen. Incidence rate of RI and rate ratio (RR) will be calculated to quantify the effect of the intervention on the incidence of respiratory infection. This will be the first trial of its kind conducted specifically in a population of older people known to have poor micronutrient status. The findings of the study may be important for similar populations in other low- and middle-income countries.
Read the detailed description
Even "subtle subclinical deficiencies of micronutrients and inadequate macronutrient intake contribute to a decline in immune function in the elderly" [1]. "The impaired regulation of the immune system in aging contributes to a higher morbidity and mortality from infections, autoimmune, and neoplastic diseases"[1]. Some studies show that either vitamins or minerals supplements may improve the immune function in older subjects [2-5 ]. Therefore, it is plausible to assume that improvement of their nutritional status through MVM supplements may benefit their ability to fight infections. The hormonal and physiological deregulation in aging might also benefit from MVM adding to the body effectiveness to deal with common pathogens in aging.
A previous systematic review and meta-analysis of randomised controlled trials (RCT), which included papers published before January 2004, found no evidence of an effect of MVM supplementation on infection rate [6] or duration [7] in older people. However, considerable clinical and methodological heterogeneity was present in the studies included in this earlier review. The investigators have updated this earlier systematically review of the evidence that MVM supplementation is effective in reducing the incidence of infection in older people. Sub-group analysis explored the effect site of residence (nursing homes or dwellings) of study participants, primary outcome measure (self report or clinical evaluation), and baseline micronutrients status of enrolled subjects [8].
The investigators found no evidence of benefits from multivitamin and minerals supplementation on the rate of infection or the odds ratio of infection in aging subjects. The investigators also found no benefit of intervention in the subgroups analysed. Sensitivity analysis of those studies evaluated as free of bias did not substantially alter this conclusion.
The included trials were heterogeneous in sample size (range 33 to 2799), duration (range 4 to 24 months), and outcome measures. The lack of benefit of the intervention in studies which found variable percent of subjects with some micronutrient deficiencies at enrolment could be related to some characteristics of the included trials: All studies but that of Avenell [9] had not determined the micronutrients status of the target population before the enrolment. Therefore, the formulas of multivitamin and mineral supplements used were not aimed to correct any pre-specified deficiency. Moreover, those studies had different considerations to define the formula, which explains the large variability of the supplements across the studies. Finally, the assessment of the micronutrient status was also variable across the studies: dietary intake evaluation and/or micronutrients blood concentration, which affects the consistency of this subgroup meta-analysis.
It is noteworthy that all studies except one [10] have been carried out in developed countries where the nutritional status of aging populations seems to be better than that reported by studies carried out in developing countries. In fact, although the variability of the assessment methods do not allow to draw a clear conclusion on the baseline nutritional status of the subjects included in the analysed studies, the prevalence of deficiencies and the number of micronutrients found deficient are evidently lower than those referred in studies from developing countries such as those carried out in Ecuador [11]. The remaining study was carried out in a middle-income country and although data on baseline nutritional status of enrolled subjects was not published, presumably their micronutrient status is somehow similar to that found in developed countries.
Based on these considerations, it would be novel to find evidence to support the hypothesis on the benefit of improving vitamin and mineral consumption, to enhance immune function and decrease infectious disease episodes in elderly suffering from extent and multiple micronutrient deficiencies as those of developing countries.
Our research group has been the first to study the nutritional, immunological, and health status of Ecuadorian older people, who live in poor peri-urban neighbourhoods of Quito, a city on the Andean Region. The investigators carried out a preliminary study of 145 older people (age ≥65 years), which revealed inadequate intake of protein and multiple micronutrients as well as high prevalence of recalled infectious diseases assessed by physician or hospital visits [12 ]. To better define these findings, the investigators performed a larger and adequately powered cross-sectional study in Quito with 352 older people (225 women), whose results have been published in two articles.[1, 11 ] Substantial deficiencies (> 30% of subjects) of serum/blood concentrations were found for vitamins C (47%), folate (32%), and zinc (43%) [1]. More than 20% of subjects were also vitamins B6, and B12 deficient [1]. Severe vitamin D deficiency was found in <15% of subjects and moderate deficiency was found in 65% of males, and 87% of females [11]. Moreover, 30% of men and 40% of women were anaemic based on altitude-adjusted haemoglobin values [1, 13]. When dietary intake was assessed the percent of deficient subjects was even higher [11].
There was correlation between dietary intake and blood concentration of some of these micronutrients [11]. Therefore, most of these older Ecuadorians suffer from multiple micronutrient deficiencies due mainly to dietary restriction. This situation makes them amenable to MVM interventions aimed to correct their nutritional status.
Blood deficiency of any one or more of the following micronutrients vitamin C, vitamin E, pyridoxal5-phosphate (PLP), folate, iron, or zinc was strongly associated with history of RI (OR 4.0; 1.76, 9.06) [1 ].
Delayed-type hypersensitivity (DTH) was considerably lower than that observed in US elderly especially to Trichophyton and tetanus toxoid [1 ] DTH is an in vivo indicator of cellular immune response status. Vitamin C and zinc concentrations were significantly associated with Interferon gamma (IFN-γ) concentrations [1]. Serum iron and zinc were significantly associated with Interleukin 2 (IL-2) levels [1]. Since IFN-γ and IL-2 are T-dependent cytokines these correlations suggest that deficiency of those micronutrients may explain the impaired cellular immune response as assessed by DTH. High plasma CRP (>3 mg/l) was present in 49% of the participants, which could be a proxy of increased pro-inflammatory cytokines [11]. There was no correlation between protein, carbohydrate, or lipid intake and immune response or infection.
Taken together, data from these previous studies in Ecuador suggest that both risk for infections and impaired immune function is associated with deficiencies of critical vitamins and minerals in Ecuadorian older people. Although it is important to be cautious to conclude on these studies due to their cross-sectional design, it seems to be necessary to evaluate a nutritional intervention intended to provide those micronutrients found to be deficient to improve the immune and health status of elderly Ecuadorians. This approach is different from that of the previous trials carried out in developed countries which had not evaluated the micronutrient status of the target population before the enrolment and, in consequence, had not defined a MVM formula aimed to correct specific deficiencies. Moreover, the micronutrients deficiencies found in Ecuadorian older subjects appear to affect largely higher percent of subjects and include more micronutrients than those found at enrolment in subjects included in studies carried out in developed countries. Therefore,the hypothesis is that provision of MVM supplements to poor Ecuadorian subjects aimed to correct their specific micronutrients deficiencies may prove beneficial to reduce the incidence of respiratory infections via improvement of their immune response assessed by DTH test, and decreased CRP concentration as proxy of the down regulation of pro-inflammatory cytokines. Since cathelicidin, an antimicrobial peptide produced by neutrophils, seems to be increased by vitamin D status [14], the measure of this peptide in supernatants of cultured cells from the upper respiratory mucosa will be included. Thus, DTH and cathelicidin would provide an assessment of both innate and adaptive immunity. This study will be the first to be undertaken in an aging population of a developing country.
- Being tested
- Multivitamins and minerals
- Keywords
- Multi-vitamins, Minerals, Respiratory infections, DTH, CRP, Cathelicidin
- Medical subject headings
- Respiratory Tract Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multivitamins and mineralsDietary supplement
Dietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Multivitamins and minerals | Experimental | Experimental: X: Multivitamins and minerals (MVM) Arm X: 1X US-RDA of vitamins A, D,E,B6,B12, folate, copper and iron plus 500 mg vitamin C, and 14 mg of Zinc Receives: Dietary Supplement: Multivitamins and minerals |
| Placebo | Placebo comparator | Not described Receives: Dietary Supplement: Multivitamins and minerals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of respiratory infections (upper plus lower)
Measured: 52 weeks
Secondary outcomes (3)
Mean score of DTH response to Trichophyton and tetanus toxoid
Measured: 52 weeks
CRP blood concentration
Measured: 52 weeks
Cathelicidin concentration in supernatants of cultured respiratory mucosa cells
Measured: 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2013 (estimated)
- Study startOct 2013
- Primary completionOct 2014 (estimated)
- Study completionDec 2014 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Upper Respiratory InfectionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 320 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Corporacion Ecuatoriana de Biotecnologia
- Sponsor type
- University, hospital or other
- Collaborators
- Universidad Central del Ecuador
- Responsible party
- Principal investigator, Fernando Sempertegui MD, Corporacion Ecuatoriana de Biotecnologia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01971112
- Sponsor's protocol ID
- 378 DGIP-I
- Status last verified
- Oct 2013
- First submitted
- 10 Oct 2013
- Last updated
- 29 Oct 2013
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Sempertegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, Sempertegui M, Griffiths JK, Noel SE, Dallal GE, Selhub J, Meydani SN. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011 May;14(5):758-67. doi: 10.1017/S1368980010002636. Epub 2010 Oct 19.
PubMed 20955641Hamer DH, Sempertegui F, Estrella B, Tucker KL, Rodriguez A, Egas J, Dallal GE, Selhub J, Griffiths JK, Meydani SN. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr. 2009 Jan;139(1):113-9. doi: 10.3945/jn.108.095091. Epub 2008 Dec 3.
PubMed 19056665Sempertegui F, Estrella B, Elmieh N, Jordan M, Ahmed T, Rodriguez A, Tucker KL, Hamer DH, Reeves PG, Meydani SN. Nutritional, immunological and health status of the elderly population living in poor neighbourhoods of Quito, Ecuador. Br J Nutr. 2006 Nov;96(5):845-53. doi: 10.1017/bjn20061802.
PubMed 17092372
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Supplementation With Multivitamins and Minerals on the Incidence of Respiratory Infections in Older People in Ecuador: a Randomised Controlled Trial.
- ClinicalTrials.gov ID
- NCT01971112
- Acronym / sponsor ID
- 378 DGIP-I
- Keywords
- Multi-vitamins, Minerals, Respiratory infections, DTH, CRP, Cathelicidin
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 320 participants (estimated)
- Lead sponsor
- Corporacion Ecuatoriana de BiotecnologiaUniversity, hospital or other
- Collaborators
- Universidad Central del Ecuador
- Study start
- Oct 2013
- Primary completion
- Oct 2014 (estimated)
- Study completion
- Dec 2014 (estimated)
- First posted
- 29 Oct 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Poor Ecuadorian older people suffer from chronic dietary deficiencies of zinc, iron, copper, vitamins C, B6, B12, D, and folic acid. The investigators have previously shown that these deficiencies are associated with impaired immune function and increased incidence of respiratory infections (RI). The hypothesis is that correction of these specific nutrient deficiencies will improve immune response and thereby enhance resistance to respiratory infections. To test this hypothesis this study will evaluate the effect of supplementation with specific vitamins and minerals found to be deficient in poor elderly Ecuadorians on markers of immune function and the incidence of RI. A randomized, double-blind, placebo-controlled trial in 320 older people (≥65 y)will be carried out in Quito, Ecuador. Participants will receive multivitamin and mineral supplements or placebo tablets daily for 12 months. Nutrients will be provided at US Recommended Daily Allowance (RDA) levels, except for vitamin C and zinc doses, which will be 5 times and 1.25 times higher than the RDA, respectively. Incidence of respiratory infections (the primary outcome) will be assessed weekly by field nurses and physicians from the study team. Secondary outcomes include delayed-type hypersensitivity (DTH) skin test, cathelicidin production by mucosa respiratory cells, and serum C-reactive protein (CRP) as measures of immune function. Blood micronutrient levels and haemoglobin status will be collected as measures of adherence to the trial regimen. Incidence rate of RI and rate ratio (RR) will be calculated to quantify the effect of the intervention on the incidence of respiratory infection. This will be the first trial of its kind conducted specifically in a population of older people known to have poor micronutrient status. The findings of the study may be important for similar populations in other low- and middle-income countries.
Detailed description
Even "subtle subclinical deficiencies of micronutrients and inadequate macronutrient intake contribute to a decline in immune function in the elderly" [1]. "The impaired regulation of the immune system in aging contributes to a higher morbidity and mortality from infections, autoimmune, and neoplastic diseases"[1]. Some studies show that either vitamins or minerals supplements may improve the immune function in older subjects [2-5 ]. Therefore, it is plausible to assume that improvement of their nutritional status through MVM supplements may benefit their ability to fight infections. The hormonal and physiological deregulation in aging might also benefit from MVM adding to the body effectiveness to deal with common pathogens in aging.
A previous systematic review and meta-analysis of randomised controlled trials (RCT), which included papers published before January 2004, found no evidence of an effect of MVM supplementation on infection rate [6] or duration [7] in older people. However, considerable clinical and methodological heterogeneity was present in the studies included in this earlier review. The investigators have updated this earlier systematically review of the evidence that MVM supplementation is effective in reducing the incidence of infection in older people. Sub-group analysis explored the effect site of residence (nursing homes or dwellings) of study participants, primary outcome measure (self report or clinical evaluation), and baseline micronutrients status of enrolled subjects [8].
The investigators found no evidence of benefits from multivitamin and minerals supplementation on the rate of infection or the odds ratio of infection in aging subjects. The investigators also found no benefit of intervention in the subgroups analysed. Sensitivity analysis of those studies evaluated as free of bias did not substantially alter this conclusion.
The included trials were heterogeneous in sample size (range 33 to 2799), duration (range 4 to 24 months), and outcome measures. The lack of benefit of the intervention in studies which found variable percent of subjects with some micronutrient deficiencies at enrolment could be related to some characteristics of the included trials: All studies but that of Avenell [9] had not determined the micronutrients status of the target population before the enrolment. Therefore, the formulas of multivitamin and mineral supplements used were not aimed to correct any pre-specified deficiency. Moreover, those studies had different considerations to define the formula, which explains the large variability of the supplements across the studies. Finally, the assessment of the micronutrient status was also variable across the studies: dietary intake evaluation and/or micronutrients blood concentration, which affects the consistency of this subgroup meta-analysis.
It is noteworthy that all studies except one [10] have been carried out in developed countries where the nutritional status of aging populations seems to be better than that reported by studies carried out in developing countries. In fact, although the variability of the assessment methods do not allow to draw a clear conclusion on the baseline nutritional status of the subjects included in the analysed studies, the prevalence of deficiencies and the number of micronutrients found deficient are evidently lower than those referred in studies from developing countries such as those carried out in Ecuador [11]. The remaining study was carried out in a middle-income country and although data on baseline nutritional status of enrolled subjects was not published, presumably their micronutrient status is somehow similar to that found in developed countries.
Based on these considerations, it would be novel to find evidence to support the hypothesis on the benefit of improving vitamin and mineral consumption, to enhance immune function and decrease infectious disease episodes in elderly suffering from extent and multiple micronutrient deficiencies as those of developing countries.
Our research group has been the first to study the nutritional, immunological, and health status of Ecuadorian older people, who live in poor peri-urban neighbourhoods of Quito, a city on the Andean Region. The investigators carried out a preliminary study of 145 older people (age ≥65 years), which revealed inadequate intake of protein and multiple micronutrients as well as high prevalence of recalled infectious diseases assessed by physician or hospital visits [12 ]. To better define these findings, the investigators performed a larger and adequately powered cross-sectional study in Quito with 352 older people (225 women), whose results have been published in two articles.[1, 11 ] Substantial deficiencies (> 30% of subjects) of serum/blood concentrations were found for vitamins C (47%), folate (32%), and zinc (43%) [1]. More than 20% of subjects were also vitamins B6, and B12 deficient [1]. Severe vitamin D deficiency was found in <15% of subjects and moderate deficiency was found in 65% of males, and 87% of females [11]. Moreover, 30% of men and 40% of women were anaemic based on altitude-adjusted haemoglobin values [1, 13]. When dietary intake was assessed the percent of deficient subjects was even higher [11].
There was correlation between dietary intake and blood concentration of some of these micronutrients [11]. Therefore, most of these older Ecuadorians suffer from multiple micronutrient deficiencies due mainly to dietary restriction. This situation makes them amenable to MVM interventions aimed to correct their nutritional status.
Blood deficiency of any one or more of the following micronutrients vitamin C, vitamin E, pyridoxal5-phosphate (PLP), folate, iron, or zinc was strongly associated with history of RI (OR 4.0; 1.76, 9.06) [1 ].
Delayed-type hypersensitivity (DTH) was considerably lower than that observed in US elderly especially to Trichophyton and tetanus toxoid [1 ] DTH is an in vivo indicator of cellular immune response status. Vitamin C and zinc concentrations were significantly associated with Interferon gamma (IFN-γ) concentrations [1]. Serum iron and zinc were significantly associated with Interleukin 2 (IL-2) levels [1]. Since IFN-γ and IL-2 are T-dependent cytokines these correlations suggest that deficiency of those micronutrients may explain the impaired cellular immune response as assessed by DTH. High plasma CRP (>3 mg/l) was present in 49% of the participants, which could be a proxy of increased pro-inflammatory cytokines [11]. There was no correlation between protein, carbohydrate, or lipid intake and immune response or infection.
Taken together, data from these previous studies in Ecuador suggest that both risk for infections and impaired immune function is associated with deficiencies of critical vitamins and minerals in Ecuadorian older people. Although it is important to be cautious to conclude on these studies due to their cross-sectional design, it seems to be necessary to evaluate a nutritional intervention intended to provide those micronutrients found to be deficient to improve the immune and health status of elderly Ecuadorians. This approach is different from that of the previous trials carried out in developed countries which had not evaluated the micronutrient status of the target population before the enrolment and, in consequence, had not defined a MVM formula aimed to correct specific deficiencies. Moreover, the micronutrients deficiencies found in Ecuadorian older subjects appear to affect largely higher percent of subjects and include more micronutrients than those found at enrolment in subjects included in studies carried out in developed countries. Therefore,the hypothesis is that provision of MVM supplements to poor Ecuadorian subjects aimed to correct their specific micronutrients deficiencies may prove beneficial to reduce the incidence of respiratory infections via improvement of their immune response assessed by DTH test, and decreased CRP concentration as proxy of the down regulation of pro-inflammatory cytokines. Since cathelicidin, an antimicrobial peptide produced by neutrophils, seems to be increased by vitamin D status [14], the measure of this peptide in supernatants of cultured cells from the upper respiratory mucosa will be included. Thus, DTH and cathelicidin would provide an assessment of both innate and adaptive immunity. This study will be the first to be undertaken in an aging population of a developing country.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Multivitamins and minerals | Experimental | Dietary Supplement: Multivitamins and mineralsExperimental: X: Multivitamins and minerals (MVM) Arm X: 1X US-RDA of vitamins A, D,E,B6,B12, folate, copper and iron plus 500 mg vitamin C, and 14 mg of Zinc |
| Placebo | Placebo comparator | Dietary Supplement: Multivitamins and minerals |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (3 listed)
- Age ≥65 years
- Mental competence
- Written informed consent
Key exclusion criteria (3 listed)
- Cancer
- Tuberculosis
- Immunosuppressive therapeutics.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multivitamins and mineralsDietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks. | Dietary supplement | Multivitamins and minerals, Placebo |
Primary outcome
Incidence of respiratory infections (upper plus lower)
Time frame: 52 weeks
3 secondary outcomes
Mean score of DTH response to Trichophyton and tetanus toxoid
Time frame: 52 weeks
CRP blood concentration
Time frame: 52 weeks
Cathelicidin concentration in supernatants of cultured respiratory mucosa cells
Time frame: 52 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2013.
- Background: PubMed 20955641Sempertegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, Sempertegui M, Griffiths JK, Noel SE, Dallal GE, Selhub J, Meydani SN. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011 May;14(5):758-67. doi: 10.1017/S1368980010002636. Epub 2010 Oct 19.
- Background: PubMed 19056665Hamer DH, Sempertegui F, Estrella B, Tucker KL, Rodriguez A, Egas J, Dallal GE, Selhub J, Griffiths JK, Meydani SN. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr. 2009 Jan;139(1):113-9. doi: 10.3945/jn.108.095091. Epub 2008 Dec 3.
- Background: PubMed 17092372Sempertegui F, Estrella B, Elmieh N, Jordan M, Ahmed T, Rodriguez A, Tucker KL, Hamer DH, Reeves PG, Meydani SN. Nutritional, immunological and health status of the elderly population living in poor neighbourhoods of Quito, Ecuador. Br J Nutr. 2006 Nov;96(5):845-53. doi: 10.1017/bjn20061802.
Related trials for Upper Respiratory Infections
Not yet recruitingPhase 4
SPARK Study - Sympathetic Periarterial Radial Block in Healthy Volunteers
Healthy Volunteers, Sympathetic Activity
Not yet recruiting
Influence of Patient Positioning During Nasal Lavage
Acute Upper Respiratory Tract Infections, Nasal Obstruction
Recruiting
Safety and Efficacy of NTP in Thyroid Surgery: Pilot Study on Morbidity Prevention and Adjuvant Oncological Control
Thyroid Diseases, Wound Healing
RecruitingObservational study
A Study to Evaluate Treating Watery Noses With Cryotherapy in the Clinic Setting. This is Cold Therapy, Freezing the Issues at the Back of the Nose to Ease Symptoms.
Chronic Rhinitis
Not yet recruiting
Evaluating Sucrose and Cold Oral Interventions for the Treatment of Oral Pruritus During Allergy Procedures.
Allergy, Food Allergies
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multivitamins and minerals in people with Upper Respiratory Infections and Lower Respiratory Tract Infections, run by Corporacion Ecuatoriana de Biotecnologia at 1 site in Ecuador.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Oct 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ecuador. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Fernando E Sempertegui, MD (593 2 2557673, fersempert@biociencias-ceb.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of respiratory infections (upper plus lower) (time frame: 52 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01971112, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2013.